Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10
Heart failure (HF) is a global epidemic that contributes to the deterioration of quality of life and its shortening in 1–3% of adult people in the world. Pharmacotherapy of HF should rely on highly effective drugs that improve prognosis and prolong life. Currently, the ESC guidelines from 2021 indic...
Main Authors: | Krzysztof J. Filipiak, Stanisław Surma, Monika Romańczyk, Bogusław Okopień |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3425/9/5/161 |
Similar Items
-
Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement
by: Anna Di Lorenzo, et al.
Published: (2020-04-01) -
Water-soluble coenzyme Q10 provides better protection than lipid-soluble coenzyme Q10 in a rat model of chronic tacrolimus nephropathy
by: Sheng Cui, et al.
Published: (2021-07-01) -
Q10 COENZYME FOR THE PROPHYLAXIS OF MIGRAINE IN CHILDREN AND ADOLESCENTS
by: Liana Tauberg
Published: (2008-06-01) -
The effects of CoenzymeQ10 on gentamicin induced nephrotoxicity
by: Zeinab Hameidi Zad, et al.
Published: (2016-10-01) -
Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy
by: Orhan Ates, et al.
Published: (2013-10-01)